anti-MIgG(Fc)Fab-C-MMAE ADC

The anti-MIgG(Fc)Fab-C-MMAE ADC is a sophisticated antibody-drug conjugate (ADC) designed for targeted cancer therapy. This ADC combines the specificity of an antibody that recognizes the Fc region of mouse immunoglobulin G (IgG) with the potent cytotoxicity of the drug monomethyl auristatin E (MMAE). By linking MMAE to the Fab fragment of the antibody, the ADC selectively targets and binds to tumor cells expressing the corresponding antigen, allowing for precise delivery of the cytotoxic agent directly to the cancer cells. This targeted approach minimizes off-target effects and enhances the therapeutic efficacy, making anti-MIgG(Fc)Fab-C-MMAE ADCs a promising strategy in the development of effective cancer treatments.